Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient. Micha J, Rettenmaier M, Giuliano P, Bohart R, et al. Anticancer Drugs 2022 Mar 23. pii: 00001813-900000000-98204.

Read + Share

Amedeo Smart

Independent Medical Education

Micha J, Rettenmaier M, Giuliano P, Bohart R, et al. Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient. Anticancer Drugs 2022 Mar 23. pii: 00001813-900000000-98204.
PMID: 35324520